PAVM · PAVmed Inc.
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the accompanying consolidated financial statements are issued.”View the 10-Q filed May 14, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-04-02 | MCGRATH DENNIS M |
President and CFO |
Award↑
Filing footnotes — Common stock (Direct)
Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |
Common stock
|
180,000 |
| 2026-04-02 | Glennon Michael J |
Director |
Award↑
Filing footnotes — Common stock (Direct)
Represents restricted stock granted to the reporting person under the issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |
Common stock
|
13,930 |
| 2026-04-02 | Baxter Timothy E |
Director |
Award↑
Filing footnotes — Common stock (Direct)
Represents restricted stock granted to the reporting person under the issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |
Common stock
|
13,930 |
| 2026-04-02 | White Debra |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed, |
Common Stock
|
13,930 |
| 2026-04-02 | O'Neil Shaun |
Chief Operating Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |
Common Stock
|
110,000 |
| 2026-04-02 | Sparks Ronald M |
Director |
Award↑
Filing footnotes — Common stock (Direct)
Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |
Common stock
|
13,930 |
| 2026-04-02 | Gordon Michael Adam |
General Counsel |
Award↑
Filing footnotes — Common stock (Direct)
Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |
Common stock
|
110,000 |
| 2026-04-02 | Aklog Lishan |
Director, Chairman and CEO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |
Common Stock
|
350,000 |
| 2026-04-02 | Agrawal Sundeep |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock granted to the reporting person under the issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |
Common Stock
|
13,930 |
| 2026-04-02 | Lee Victoria Tou-ho |
Chief Medical Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |
Common Stock
|
70,000 |
| 2025-09-30 | Gordon Michael Adam |
General Counsel |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock granted to the reporting person under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |
Common Stock
|
150,000 |
| 2025-09-30 | White Debra |
Director |
Award↑
Filing footnotes — Common stock (Direct)
Represents restricted stock granted to the reporting person under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |
Common stock
|
150,000 |
| 2025-09-30 | MCGRATH DENNIS M |
President and CFO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock granted to the reporting person under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |
Common Stock
|
150,000 |
| 2025-09-30 | Aklog Lishan |
Director, Chairman and CEO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock granted to the reporting person under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |
Common Stock
|
150,000 |
| 2025-09-30 | Agrawal Sundeep |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock granted to the reporting person under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |
Common Stock
|
150,000 |
| 2025-09-30 | Glennon Michael J |
Director |
Award↑
Filing footnotes — Common stock (Direct)
Represents restricted stock granted to the reporting person under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |
Common stock
|
150,000 |
| 2025-09-30 | O'Neil Shaun |
Chief Operating Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock granted to the reporting person under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |
Common Stock
|
150,000 |
| 2025-09-30 | Sparks Ronald M |
Director |
Award↑
Filing footnotes — Common stock (Direct)
Represents restricted stock granted to the reporting person under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |
Common stock
|
150,000 |
| 2025-09-30 | Baxter Timothy E |
Director |
Award↑
Filing footnotes — Common stock (Direct)
Represents restricted stock granted to the reporting person under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |
Common stock
|
150,000 |
| 2024-10-21 | Agrawal Sundeep |
Director |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
One third of the option vests on June 30, 2025; the balance vests in eight equal quarterly installments, starting September 30, 2025. |
Employee stock option (right to buy)
|
50,000 |
| 2024-09-19 | Agrawal Sundeep |
Director |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
One third of the option vests on June 30, 2025; the balance vests in eight equal quarterly installments, starting September 30, 2025. |
Employee stock option (right to buy)
|
205,000 |
| 2024-02-22 | Cox James L |
Director |
Award↑
Filing footnotes — Common stock (Direct)
The issuer granted 65,000 shares of restricted stock to the reporting person pursuant to its long term incentive equity plan. |
Common stock
|
65,000 |
| 2024-02-22 | Sparks Ronald M |
Director |
Award↑
Filing footnotes — Common stock (Direct)
The issuer granted 65,000 shares of restricted stock to the reporting person pursuant to its long term incentive equity plan. |
Common stock
|
65,000 |
| 2024-02-22 | White Debra |
Director |
Award↑
Filing footnotes — Common stock (Direct)
The issuer granted 65,000 shares of restricted stock to the reporting person pursuant to its long term incentive equity plan. |
Common stock
|
65,000 |
| 2024-02-22 | Baxter Timothy E |
Director |
Award↑
Filing footnotes — Common stock (Direct)
The issuer granted 65,000 shares of restricted stock to the reporting person pursuant to its long term incentive equity plan. |
Common stock
|
65,000 |
| 2024-02-22 | Glennon Michael J |
Director |
Award↑
Filing footnotes — Common stock (Direct)
The issuer granted 65,000 shares of restricted stock to the reporting person pursuant to its long term incentive equity plan. |
Common stock
|
65,000 |
| 2024-02-22 | Harvey Joan B |
Director |
Award↑
Filing footnotes — Common stock (Direct)
The issuer granted 65,000 shares of restricted stock to the reporting person pursuant to its long term incentive equity plan. |
Common stock
|
65,000 |
| 2023-01-30 | Baxter Timothy E |
Director |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
One third of the option vests on March 31, 2023; the balance vests in eight equal quarterly installments, starting June 30, 2023. |
Employee stock option (right to buy)
|
450,000 |
| 2023-01-30 | Sparks Ronald M |
Director |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
One third of the option vests on March 31, 2023; the balance vests in eight equal quarterly installments, starting June 30, 2023. |
Employee stock option (right to buy)
|
450,000 |
| 2023-01-30 | Harvey Joan B |
Director |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
One third of the option vests on March 31, 2023; the balance vests in eight equal quarterly installments, starting June 30, 2023. |
Employee stock option (right to buy)
|
450,000 |
| 2023-01-30 | White Debra |
Director |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
One third of the option vests on March 31, 2023; the balance vests in eight equal quarterly installments, starting June 30, 2023. |
Employee stock option (right to buy)
|
450,000 |
| 2023-01-30 | Glennon Michael J |
Director |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
One third of the option vests on March 31, 2023; the balance vests in eight equal quarterly installments, starting June 30, 2023. |
Employee stock option (right to buy)
|
450,000 |
| 2023-01-30 | Cox James L |
Director |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
One third of the option vests on March 31, 2023; the balance vests in eight equal quarterly installments, starting June 30, 2023. |
Employee stock option (right to buy)
|
450,000 |
| 2022-12-07 | Glennon Michael J |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.6122 to $0.6382 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
Common Stock
|
100,000 |
| 2022-12-06 | Glennon Michael J |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.5930 to $0.6746 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
Common Stock
|
88,000 |
| 2022-12-05 | Glennon Michael J |
Director |
Buy↑
Filing footnotes — Common stock (Direct)
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.67 to $0.6984 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
Common stock
|
62,000 |
| 2022-06-07 | Gordon Michael Adam |
General Counsel |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
The option vests in 12 quarterly installments, with first installment vesting June 30, 2022. |
Employee stock option (right to buy)
|
400,000 |
| 2022-05-31 | Gordon Michael Adam |
General Counsel |
Other↑
|
No Securities Owned
|
0 |
| 2022-05-04 | O'Neil Shaun |
Chief Operating Officer |
Tax↓
Filing footnotes — Common stock (Direct)
Payment of payroll withholding tax liability using a portion of securities received from the company. Includes shares purchased pursuant to the company's Employee Stock Purchase Plan in transactions exempt from Section 16(a) reporting obligations. |
Common stock
|
25,935 |
| 2022-03-28 | MCGRATH DENNIS M |
President and CFO |
Tax↓
Filing footnotes — Common stock (Direct)
Payment of payroll withholding tax liability using a portion of securities received from the company. |
Common stock
|
199,973 |
| 2022-03-28 | Aklog Lishan |
Director, Chairman and CEO |
Tax↓
Filing footnotes — Common stock (Direct)
Payment of payroll withholding tax liability using a portion of securities received from the company. |
Common stock
|
79,636 |
| 2022-02-22 | O'Neil Shaun |
Chief Operating Officer |
Tax↓
Filing footnotes — Common stock (Direct)
Disposal is in connection with the payment of payroll taxes. |
Common stock
|
75,000 |
| 2022-02-22 | O'Neil Shaun |
Chief Operating Officer |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
The option vests in twelve quarterly installments, with the first twelfth vesting March 31, 2022. |
Employee stock option (right to buy)
|
300,000 |
| 2022-02-18 | Baxter Timothy E |
Director |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
The option vests in 12 quarterly installments, with first installment vesting March 31, 2022. |
Employee stock option (right to buy)
|
80,000 |
| 2022-02-18 | Sparks Ronald M |
Director |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
The option vests in 12 quarterly installments, with first installment vesting March 31, 2022. |
Employee stock option (right to buy)
|
80,000 |
| 2022-02-18 | White Debra |
Director |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
The option vests in 12 quarterly installments, with first installment vesting March 31, 2022. |
Employee stock option (right to buy)
|
80,000 |
| 2022-02-18 | Cox James L |
Director |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
The option vests in 12 quarterly installments, with first installment vesting March 31, 2022. |
Employee stock option (right to buy)
|
80,000 |
| 2022-02-18 | Glennon Michael J |
Director |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
The option vests in 12 quarterly installments, with first installment vesting March 31, 2022. |
Employee stock option (right to buy)
|
80,000 |
| 2022-02-18 | DeGuzman Brian J. |
Chief Medical Officer |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
The option vests in 12 quarterly installments, with first installment vesting March 31, 2022. |
Employee stock option (right to buy)
|
50,000 |
| 2022-02-18 | MCGRATH DENNIS M |
President and CFO |
Award↑
Filing footnotes — Employee stock option (right to buy) (Direct)
The option vests in 12 quarterly installments, with first installment vesting March 31, 2022. |
Employee stock option (right to buy)
|
150,000 |